Investigation
An open-source investigation into the ingredients, manufacturing supply chains, and safety records of every ADHD medication sold in the United States.
Inspired by ProPublica’s Rx Inspector investigation into generic drug manufacturing transparency.
12
Drugs Tracked
150
Manufacturers
16,729
Ingredient Records
2,700
Label Versions
236
FDA Recalls
203
Formulation Changes
This project is a work in progress
The database is actively being expanded with additional drugs, manufacturers, and data sources. Existing data is continuously refined for accuracy. If you find discrepancies or have suggestions, reach out at hello@whatsinmymeds.com.
Generic Vyvanse manufacturers use between 14 and 20 inactive ingredients. Six ingredients in Sun Pharma's generic aren't in Takeda's brand-name version. We let you compare every manufacturer, side by side.
Brand-name Vyvanse declares 5 manufacturing facilities. The Sun Pharma generic declares 1 — despite an 18-facility global network. When that facility failed, all 7 dosage strengths were recalled at once.
We found 203 instances where manufacturers changed their inactive ingredients across 2,700 label versions. Patients are never notified. Our timeline tracks every change, every date, every ingredient.